Name

Xofigo

Alternate Names

Radium 223
Radium Ra 223 dichloride

Abbreviations

None

Category

Radiation

Subcategory

Alpha-particle emitting radio-theraputic drug

NSC Number

None

Primary Site

Metastatic prostate cancer

Histology

None

Remarks

July 2013 UPDATE: Radium Ra 223 dichloride received FDA approval for the treatment of patients with castration-resistant prostate cancer, symptomatic bone metastases and no know visceral metastatic disease. This radioisotope is administered via injection and should be coded in the Radiation Therapy data fields. Because the drug emits radioactive particles, it has to be given by a radiation oncologist or nuclear medicine specialist.

Coding

This drug should be coded
Glossary